"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study

Research output: Contribution to journalJournal articleResearchpeer-review

  • M Vervloet
  • V Bencova
  • F Malberti
  • N Ashman
  • I Os
  • H Saha
  • P Ureña
  • E Zitt
  • M Rix
  • M Ryba
  • D Fouque
  • B Dehmel
  • F Petavy
  • Stephen Jacobson
The pan-European ECHO observational study evaluated cinacalcet in adult dialysis patients with secondary hyperparathyroidism (SHPT) in "real-world" clinical practice. A sub-analysis compared data for 7 European countries/country clusters: Austria, CEE (Czech Republic and Slovakia), France, Italy, Netherlands, Nordics (Denmark, Finland, Norway, and Sweden), and the UK/Ireland.
Original languageEnglish
JournalClinical Nephrology
Volume74
Issue number3
Pages (from-to)198-208
Number of pages11
ISSN0301-0430
Publication statusPublished - 1 Sep 2010

ID: 34087952